Showing 19,921 - 19,940 results of 103,727 for search '(( 2 step decrease ) OR ( 5 ((non decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.65s Refine Results
  1. 19921
  2. 19922
  3. 19923

    Managing Impending Non-Severe Hypoglycemia with Oral Carbohydrates in Type 1 Diabetes: The REVERSIBLE Trial. by Ran Cheng (8449275)

    Published 2024
    “…Following inpatient subcutaneous insulin-induced decrease in BG in the fasting state, 16g of oral CHO was administered at a plasma glucose (PG) of <70 mg/dL (3.9 mmol/L), ≤80 mg/dL (4.5 mmol/L) or ≤90 mg/dL (5.0 mmol/L). …”
  4. 19924
  5. 19925

    Table_1_Enhanced immune reconstitution with albuvirtide in HIV-infected immunological non-responders.docx by Lina Fan (2211169)

    Published 2024
    “…</p>Methods<p>In this prospective, open-label, controlled clinical study, participants with incomplete immune reconstitution (continuous ART over 5 years and CD4<sup>+</sup>T lymphocyte absolute count of <500 cells/µl or ART for 2–5 years and CD4<sup>+</sup>T cell count of <200 cells/µl with undetectable viral load) were received intensive treatment with ABT or maintained on the original ART regimen at a ratio of 1:1. …”
  6. 19926

    Ldb2a knockdown promotes the specification of mesendoderm and mesoderm. by Wenchao Gu (344453)

    Published 2015
    “…(A–D): three independent experiments, with the total number of analysed embryos shown in each panel; (F–G): five independent experiments; (H–I): one experiment; (J–O): three independent experiments. …”
  7. 19927

    Table 1_Mendelian randomization provides causal association between COVID-19 and thyroid cancer: insights from a multi-cancer analysis.xlsx by Shuhong Li (151480)

    Published 2024
    “…The findings indicate that COVID-19 has negligible impact on most cancer risks. Interestingly, a higher COVID-19 impact is associated with a decreased risk of thyroid cancer. …”
  8. 19928
  9. 19929
  10. 19930
  11. 19931
  12. 19932
  13. 19933

    Table 1_A multicenter, prospective cohort study on the anti-SARS-CoV-2 vaccination response in patients with multiple sclerosis in Germany.docx by Achim Berthele (226193)

    Published 2025
    “…</p>Conclusions<p>With the exception of anti-CD20 antibodies and S1PR modulators, DMTs did not impair humoral response to any of the authorized SARS-CoV-2 vaccines. Persistence of humoral immune response was seen over a period of at least 3 months in the majority of initial responders but was decreased in the anti-CD20 antibodies/S1PR modulator subgroup.…”
  14. 19934
  15. 19935

    Data_Sheet_1_Colistin Combined With Tigecycline: A Promising Alternative Strategy to Combat Escherichia coli Harboring blaNDM–5 and mcr-1.pdf by Yu-Feng Zhou (416164)

    Published 2020
    “…A concentration-dependent decrease in colistin MIC and EC<sub>50</sub> was observed with increasing tigecycline levels. …”
  16. 19936

    Image_1_Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients.TIF by Arkadiusz Pietrasik (12879863)

    Published 2022
    “…</p>Objective<p>We conducted a systematic review with meta-analysis to compare the efficacy and safety of CDT and ST in intermediate-high and high-risk PE.…”
  17. 19937

    Image_4_Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients.TIF by Arkadiusz Pietrasik (12879863)

    Published 2022
    “…</p>Objective<p>We conducted a systematic review with meta-analysis to compare the efficacy and safety of CDT and ST in intermediate-high and high-risk PE.…”
  18. 19938

    Image_6_Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients.TIF by Arkadiusz Pietrasik (12879863)

    Published 2022
    “…</p>Objective<p>We conducted a systematic review with meta-analysis to compare the efficacy and safety of CDT and ST in intermediate-high and high-risk PE.…”
  19. 19939

    Image_2_Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients.TIF by Arkadiusz Pietrasik (12879863)

    Published 2022
    “…</p>Objective<p>We conducted a systematic review with meta-analysis to compare the efficacy and safety of CDT and ST in intermediate-high and high-risk PE.…”
  20. 19940

    Image_7_Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients.TIF by Arkadiusz Pietrasik (12879863)

    Published 2022
    “…</p>Objective<p>We conducted a systematic review with meta-analysis to compare the efficacy and safety of CDT and ST in intermediate-high and high-risk PE.…”